# Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

Article · Joy Hsu, Jonathan J. Hodgins, Malvika Marathe, Christopher J. Nicolai, Marie‐Claude Bourgeois‐Daigneault, Troy N. Trevino, Camillia S. Azimi, Amit K. Scheer, Haley E. Randolph, Thornton W. Thompson, Lily Zhang, Alexandre Iannello, Nikhita Mathur, Karen E. Jardine, Georgia A. Kirn, John Cameron Bell, Michael W. McBurney, David H. Raulet, Michele Ardolino

- Archive id: doi:10.1172/jci99317
- Published: 2018-09-09
- Venue: Journal of Clinical Investigation
- DOI: https://doi.org/10.1172/jci99317
- PMID: 30198904
- Citations: 816
- Source URL: https://doi.org/10.1172/jci99317
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.
